What is mucuna pruriens?
Mucuna pruriens (velvet bean) is a tropical legume whose seeds are naturally rich in levodopa, the main drug used for Parkinson's disease. It has long been used in traditional Ayurvedic Indian medicine, and it is sold as a supplement and studied as a low-cost levodopa source for Parkinson's.
Also known as: Mucuna, velvet bean, kapikachhu, L-dopa bean.
Amounts studied
Parkinson's trials used single doses of 15 g and 30 g of a mucuna preparation (Katzenschlager 2004) and single weight-based doses of roasted seed powder (Cilia 2017); in a 12-month trial, doses were adjusted for body weight and disease stage (Cilia, 12-month trial). These are study protocols, not a recommendation.
Approval status and how it is used
It is sold in the US as a dietary supplement. Under the 1994 dietary supplement law (DSHEA), FDA does not approve dietary supplements before they are marketed, and the maker, not FDA, is responsible for safety and labeling.
What studies show: in a small 2004 trial of 8 people with Parkinson's, 30 g of mucuna worked faster and gave higher levodopa levels than standard levodopa/carbidopa, without more dyskinesias (involuntary movements). In a 2017 crossover trial of 18 people with advanced Parkinson's, single doses of mucuna powder performed as well as standard levodopa with fewer side effects. A 12-month trial in 32 people with untreated Parkinson's in sub-Saharan Africa found results similar to standard levodopa; side effects were more common with mucuna (56% vs 37.5%), though the difference was not statistically significant.
Risks: a 2026 review by Parkinson's specialists says mucuna is a potent dopamine therapy that needs the same caution as prescription levodopa. Overuse and unsupervised self-treatment have been linked to dyskinesia, dopamine dysregulation syndrome and psychiatric problems, and improper seed preparation has caused toxicity. The authors say its use should stay within clinical trials or neurologist-led care until there is more long-term safety evidence.
Mucuna pruriens half-life and time to peak
- Half-lifeNot listed
- Time to peak (Tmax)Not listed
We could not find a single published half-life or time to peak for mucuna that applies to a supplement dose, so we do not list one. Herbal products are mixtures of many plant compounds, so no single figure would describe them. In one trial, 30 g of mucuna reached peak levodopa levels faster than standard levodopa/carbidopa and took effect in about 35 minutes versus about 69 minutes (Katzenschlager 2004).
How to track mucuna pruriens in Dose Track
- Add mucuna pruriens as a custom compound. Start typing its name and Dose Track fills in the details from its research library for you to check, and it sits next to everything else you take.
- Log each dose when you take it so your history shows exactly what you took and when.
- Set reminders on your own schedule, whether that is daily, weekly or every few days.
- Your log is stored on your phone and no account is needed. Data only leaves it for features you choose, like AI answers and lab reading.
How Dose Track handles peptides · Reconstitution calculator · Half-life calculator
Related compounds
Frequently asked questions
What is the half-life of mucuna pruriens?+
Does Mucuna pruriens contain L-dopa?+
Is it safe to take mucuna on my own?+
Can I track mucuna pruriens in Dose Track?+
Sources
- Katzenschlager R, et al. Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry. 2004;75(12):1672-1677.
- Cilia R, Katzenschlager R. "To bean or not to bean": therein lie the hype and the hope. Advice to people with Parkinson in my clinic about Mucuna pruriens. J Parkinsons Dis. 2026;16(4):788-794.
- Cilia R, et al. Mucuna pruriens in untreated Parkinson's disease in sub-Saharan Africa: a 12-month, multicenter, randomized, controlled trial. J Parkinsons Dis. 2026;16(1):99-109.
- Cilia R, et al. Mucuna pruriens in Parkinson disease: a double-blind, randomized, controlled, crossover study. Neurology. 2017;89(5):432-438.
- FDA. Questions and answers on dietary supplements.
See also
- Fadogia Agrestis: half-life, strengths and approval status
- Panax Ginseng (Asian or Korean Ginseng): half-life, strengths and approval status
- Eleuthero (Siberian Ginseng): half-life, strengths and approval status
- Cordyceps: half-life, strengths and approval status
- Schisandra: half-life, strengths and approval status
Track it in Dose Track: GLP-1 tracker, TRT tracker or peptide tracker.